VitaSpring Biomedical Co. Ltd. reported earnings results for the first quarter ended April 30, 2022. For the first quarter, the company reported sales was USD 1.49 million compared to USD 0.5338 million a year ago.

Net income was USD 0.276656 million compared to USD 0.235662 million a year ago.